ANAPTYSBIO, INC
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Phone 858-362-6295
Fiscal Year End 1231
EIN 203828755
Financial Overview
FY2025
$262.10M
Stockholders' Equity
$-6.08
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 10-K Annual financial report | March 3, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
Annual Reports
10-K March 3, 2026
- Strong financial health with approximately $300 million in cash, cash equivalents, and marketable securities as of December 31, 2023, and minimal long-term debt.
- Significant strategic partnerships, including GSK for JEMPERLI (Dostarlimab) royalties and Vanda Pharmaceuticals for a GPP treatment, providing reliable funding and future milestone potential.
Material Events
8-K Strategy Change March 27, 2026
High Impact
- Spin-off of First Tracks Biotherapeutics (TRAX) creates a pure-play clinical development entity.
- AnaptysBio (ANAB) transitions into a streamlined, royalty-focused entity managing JEMPERLI revenue.
Insider Trading
STRONG SELL 6 insiders
38 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.